August 29th 2025
The authors examine common FDA 483 findings and outline strategies to address and prevent regulatory non-compliance.
DCAT Week 2025: Expanding Sterile Injectables Capacity
March 18th 2025PharmTech Group interviewed Lee Karras of Noramco live on site at DCAT Week 2025, shortly after the company announced a $25 million investment in sterile injectable manufacturing capabilities at its Halo Pharma facility in New Jersey.
DCAT Week 2025: Maintaining Aseptic Integrity and Stability in Sterile Injectable Manufacturing
March 18th 2025Lidia Serina, PhD, head of Development Services at Simtra BioPharma Solutions, discusses the challenges with maintaining aseptic integrity in the manufacturing of sterile injectable pharmaceuticals.
Industry Outlook 2025: Personalizing Precision Medicine and Adopting AI
February 28th 2025BioPharm International® chatted with Preeya Beczek, managing director and co-founder of Beczek.COM, about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Lilly Plans New US Pharmaceutical Manufacturing Sites in Wake of Trump Tariffs
February 27th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.